Identification of Essential Genes and Drug Discovery in Bladder Cancer and Inflammatory Bowel Disease via Text Mining and Bioinformatics Analysis
Author:
Affiliation:
1. Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China
2. Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China
Abstract
Funder
Hubei Province Key Research and Development Project
Central Guiding Local Science and Technology Development Project
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Molecular Medicine,General Medicine
Reference41 articles.
1. Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021,71(3),209-249
2. Witjes J.A.; Bruins H.M.; Cathomas R.; Compérat E.M.; Cowan N.C.; Gakis G.; Hernández V.; Linares Espinós E.; Lorch A.; Neuzillet Y.; Rouanne M.; Thalmann G.N.; Veskimäe E.; Ribal M.J.; van der Heijden A.G.; European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. Eur Urol 2021,79(1),82-104
3. Zhang C.; Liu S.; Peng L.; Wu J.; Zeng X.; Lu Y.; Shen H.; Luo D.; Does inflammatory bowel disease increase the risk of lower urinary tract tumors: A meta-analysis. Transl Androl Urol 2021,10(1),164-173
4. Geng Z.; Geng Q.; Risk of urinary bladder cancer in patients with inflammatory bowel diseases: A meta-analysis. Front Surg 2021,8,636791
5. Ghandour R.; Singla N.; Lotan Y.; Treatment options and outcomes in nonmetastatic muscle invasive bladder cancer. Trends Cancer 2019,5(7),426-439
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers;Frontiers in Genetics;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3